ADC Therapeutics S.A.



After Hours

 --Quotes are delayed by 20 min

Jul 6, 2022, 4:59 p.m.





-0.33 -0.56%


Volume 1,085

Quotes are delayed by 20 min


Previous close

$ 8.85

$ 8.94


+0.09 +1.02%

Day low

Day high




52 week low

52 week high




Annual Financials for ADC Therapeutics S.A.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 1.8M1.14M2.34M-33.92M
Cost of Goods Sold (COGS) incl. D&A ---1.97M3.97M
COGS excluding D&A ----1.34M
Depreciation & Amortization Expense 341,000513,0001.65M1.97M2.63M
Depreciation 328,000488,0001.62M1.93M2.5M
Amortization of Intangibles 13,00025,00030,00047,000129,000
Gross Income ---(1.97M)29.94M
20172018201920202021 5-year trend
SG&A Expense 93.13M126.34M118.44M216.49M291.3M
Research & Development 85.33M117.74M104.62M139.71M155.53M
Other SG&A 7.81M-13.81M76.78M-
Other Operating Expense -----
Unusual Expense -227,000-47.2M(34.89M)
EBIT after Unusual Expense -(125.94M)-(265.66M)(226.46M)
Non Operating Income/Expense 825,000213,000(255,000)(576,000)50,000
Non-Operating Interest Income 1.03M2.86M2.25M832,00066,000
Equity in Affiliates (Pretax) -----
Interest Expense --156,0004.93M18.49M
Gross Interest Expense --156,0004.93M18.49M
Interest Capitalized -----
Pretax Income (89.81M)(122.87M)(115.9M)(270.33M)(244.83M)
Income Tax 48,000224,000582,000327,000(21.48M)
Income Tax - Current Domestic 48,000224,000582,000327,0004.57M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic ----(26.05M)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates ---24.37M(6.67M)
Other After Tax Income (Expense) -----
Consolidated Net Income (89.86M)(123.1M)(116.48M)(246.29M)(230.03M)
Minority Interest Expense -----
Net Income (89.86M)(123.1M)(116.48M)(246.29M)(230.03M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (89.86M)(123.1M)(116.48M)(246.29M)(230.03M)
Preferred Dividends -----
Net Income Available to Common (89.86M)(123.1M)(116.48M)(246.29M)(230.03M)
EPS (Basic) (28,664.00)(33,019.00)(1.74)(3.77)(3.00)
Basic Shares Outstanding 3,1353,72866.87M65.41M76.75M
EPS (Diluted) (28,664.00)(33,019.00)(1.74)(3.77)(3.00)
Diluted Shares Outstanding 3,1353,72866.87M65.41M76.75M
EBITDA (91.33M)(125.2M)(116.1M)(216.49M)(258.72M)
Link to MarketWatch's Slice.